Overview

Where It All Began

We started here in 2010, and this is still the biggest part of what we do. Active pharmaceutical ingredients, finished dosages, manufacturing through qualified partner facilities, and the regulatory work that turns a good product into an approved one.

Where it all began, 2010.

Strong partners, chosen carefully, kept for years.

Strong partners, kept for years.

More patients reached, more markets served, the same bar throughout.

More patients, more markets, the same bar.
What We Offer

Our Core Segments

All products are developed and manufactured to meet international regulatory standards.

API (Active Pharmaceutical Ingredients)

Sourcing and supply of raw materials that meet global quality standards.

Finished Dosage Form

End-to-end delivery of medicines ready for patients across regulated and emerging markets.

Contract Manufacturing (CMO)

Contract manufacturing partnerships that scale production without compromising quality.

Consulting & Advisory in Healthcare & Pharma

Regulatory and strategic advisory support for partners navigating global healthcare markets.

Our Approach

Why Akira Pharma

Therapeutic Excellence

Scientific rigor and innovation focused on improving patient outcomes.

Accredited Network

We work only through sites that already satisfy the regulators of the markets we serve.

Global Accessibility

Regulatory and distribution expertise that gets products to markets around the world.

Our Products

The portfolio spans key therapeutic areas and dosage forms, delivered through trusted sourcing, manufacturing, and distribution partnerships with a patient-centered approach adapted for each market.

Therapeutics

Oncology
Neuroscience
Cardiovascular
Diabetes
Ophthalmology

Dosage Forms

Tablets
Capsules
Drops
Inhalers
Transdermal Patches
Global Presence

Markets We're Targeting

Akira Pharma is building its international footprint across five priority markets.

Japan Turkey United States United Kingdom India